APA (7th ed.) Citation

S, M. P., A, R. L., A, G., G, I. G., LA, F., S, O. G., . . . JA, G. (2025). Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y). Frontiers in psychiatry, 16, 1540213. https://doi.org/10.3389/fpsyt.2025.1540213

Chicago Style (17th ed.) Citation

S, Manchado Perero, et al. "Long-term Effectiveness, Adherence and Safety of Twice-yearly Paliperidone-palmitate Long Acting-injectable in Patients with Schizophrenia in Europe: 2-year Mirror-image Data from the Paliperdone-2 Per Year Study (P2Y)." Frontiers in Psychiatry 16 (2025): 1540213. https://doi.org/10.3389/fpsyt.2025.1540213.

MLA (9th ed.) Citation

S, Manchado Perero, et al. "Long-term Effectiveness, Adherence and Safety of Twice-yearly Paliperidone-palmitate Long Acting-injectable in Patients with Schizophrenia in Europe: 2-year Mirror-image Data from the Paliperdone-2 Per Year Study (P2Y)." Frontiers in Psychiatry, vol. 16, 2025, p. 1540213, https://doi.org/10.3389/fpsyt.2025.1540213.